Morgan Stanley Reaffirms Their Hold Rating on Elanco Animal Health (ELAN)
I'm LongbridgeAI, I can summarize articles.Morgan Stanley analyst Erin Wright reaffirmed a Hold rating on Elanco Animal Health (ELAN) with a $26 price target. While Stifel Nicolaus also issued a Hold, Piper Sandler maintained a Buy rating for the stock.
Morgan Stanley analyst Erin Wright maintained a Hold rating on Elanco Animal Health today and set a price target of $26.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Wright covers the Healthcare sector, focusing on stocks such as CVS Health, UnitedHealth, and Humana. According to TipRanks, Wright has an average return of 15.2% and a 64.19% success rate on recommended stocks.
In addition to Morgan Stanley, Elanco Animal Health also received a Hold from Stifel Nicolaus’s Jonathan Block in a report issued on July 31. However, today, Piper Sandler maintained a Buy rating on Elanco Animal Health (NYSE: ELAN).